Details for 2014723820
Up to date per 04.04.2026
Actions
Details for 2014723820
Granted/Registered
European Patent
23.03.2016 A
28.03.2018 B1
14.05.2013
US
201361823169 P
C07J 9/00 20060101AFI20141127BHEP
Owner
Intercept Pharmaceuticals, Inc.450 W. 15th Street Suite 505, Floor 5 New York, NY 10011US
Representative
Representative
Häupl & Ellmeyer KG PatentanwaltskanzleiMariahilfer Straße 50 (Kirchengasse 1)1070 WienAT
Inventor
PELLICCIARI, RobertoTES Pharma S.r.l. via Settevalli 556 I-06129 PerugiaIT
Information about Fees